Pregnancy and breast feeding mother;
Estimated life expectancy <12 months;
Scheduled major surgery in the next 6 months;
Inability to follow the protocol and comply with follow-up requirements or any other reason that the investigator feels would place the patient at increased risk;
Previous enrolment in this study or treatment with an investigational drug or device under another study protocol in the past 30 days.
WHO group II, III, IV, V PH
Severe Renal dysfunction (Ccr<30 ml/min)
Blood platelet count<100,000/L
Expected life span<6-month
Systematical inflammation
Malignant cancer(s)
Tricuspid valve stenosis, Supra-pulmonary valve stenosis
Allergic to studied drugs or metal materials.
